Drug interaction between sevelamer and cyclosporin [8]

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1939-1940

  Wauters, Jean Pierre ^a   Uehlinger, Dominik ^a   Marti, Hans Peter ^a  

^a PSI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM HYDROXIDE; BILE ACID; CALCIUM SALT; CHOLESTEROL; COLESTYRAMINE; CYCLOSPORIN; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PHOSPHATE; PHOSPHATE BINDING AGENT; POLYMER; SEVELAMER; TACROLIMUS; VITAMIN D; VITAMIN K GROUP;

BILE; CASE REPORT; DRUG ABSORPTION; DRUG BINDING; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG SPECIFICITY; GASTROINTESTINAL TRACT; HEMODIALYSIS; HUMAN; LETTER; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RISK ASSESSMENT;

CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EPOXY COMPOUNDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POLYAMINES; POLYETHYLENES;

EID: 3242698015     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh298     Document Type: Letter

References (4)

1. Guillen-Anaya MA, Jadoul M. Drug interaction between sevelamer and cyclosporin. Nephrol Dial Transplant 2004; 19: 515
2. Trull AK, Tan KKC, Tan L et al. Absorption of cyclosporin from conventional and new micro-emulsion oral formulations in liver transplant recipients with external bile diversion. Br J Clin Pharmacol 1995; 39: 627-631
3. Jensen RA, Lal SM, Diaz-Arias A et al. Does cholestyramine interfere with cyclosporine absorption? Prospective study in renal transplant patients. ASAIO J 1995; 41: 704-706.
4. Product Information Brochure USA and Summary of Product Characteristics of the EMEA.